NHS England’s chief executive has told MPs he would support an independent review of the effectiveness of Palantir’s ...
Palantir Technologies (NASDAQ:PLTR) dropped 3.3% this week, closing at $131.41 on Friday. That extends a brutal year-to-date decline of 26%, despite blowout earnings less than two weeks ago. While the ...
Opinion
I investigated Palantir’s foothold in the British state – and what I found should worry us all
Paid-for political access and threadbare regulations have helped to embed the US tech firm in the NHS – and beyond. But there is a way to free ourselves, says Peter Geoghegan of Democracy for Sale ...
Palantir Technologies Inc. is positioned for long-term growth, driven by catalysts unveiled at AIPCon 10. Learn more about ...
For anyone holding Palantir (PLTR) stock, the numbers can feel like a paradox. The company just posted 85% year-over-year revenue growth, yet the stock has been under pressure, falling 25% over the ...
It's undeniable that Palantir is growing quickly. Revenue was up 70% year over year last quarter to $1.41 billion, with accelerating growth over the last few years as the company captures ...
Britain is conducting ​a full review of its National Health Service contract with U.S. data analytics ‌firm Palantir , amid growing political pressure for the government to use a break clause at the ...
FAA is turning to AI to reduce the number of close calls between planes at the nation’s airports - Federal Aviation Administration reportedly inks deal with Palantir to analyze incident data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results